Moneycontrol

Budget 2023Budget 2023
Register Now : Nifty Banker 3.0 | India's First Retail Index Traders Online Conference.
Budget 2023
Budget 2023
you are here: HomeNewsBusiness

Chiron Behring relaunches rabies vaccine under ChiroRab brand

Bharat Biotech acquired Chiron Behring from GSK in March this year and commercial operations at the company's Ankleshwar (Gujarat) unit restarted in May.

November 13, 2019 / 03:52 PM IST

Chiron Behring Vaccines, a part of Bharat Biotech, on November 13 relaunched its rabies vaccine in the country under the ChiroRab brand. The company used to market the vaccine under the trade name Rabipur earlier.

Bharat Biotech acquired Chiron Behring from GSK in March this year and commercial operations at the company's Ankleshwar (Gujarat) unit restarted in May.

"The new vaccine is being manufactured using the same technology (as Rabipur) at the same site...we were highly committed in expediting the manufacturing and commercialisation of ChiroRab," Bharat Biotech Chairman and MD Krishna Ella told reporters here.

The vaccine would be made available for government hospitals in various states through tenders and the remaining lot for private market and exports, he added.